Chamlion Closes 236M Yuan in Series B Funding
Chamlion, a Nanjing, China-based company focused on the digitalization of processes of dentistry, raised 236M Yuan in Series B funding.
Chamlion, a Nanjing, China-based company focused on the digitalization of processes of dentistry, raised 236M Yuan in Series B funding.
SJ Semiconductor Corporation, a JianGyin, China-based provider of first-class Middle-End-Of-Line (MEOL) manufacturing and testing services, signed $340m Series C+ financing.
DeepWay, a Beijing, China-based smart commercial vehicle developer and manufacturer, raised ¥770M in Series A+ funding.
SiYi Intelligence, a Shangai, China-based intelligent rehabilitation solution provider, completed nearly USD15m in Series A financing.
Zhuhai Kingsware Information Technology, a Zhuhai, China-based provider big data processing, information system integration, and other services, raised RMB 500M in Series C+ funding.
TandemAI, a Suzhou, and Shanghai, China- and New York-based technology company focused on transforming drug discovery infrastructure, raised $35M in Series A funding.
SHANGHAI, CHINA — Recently, Ronovo Surgical invited top gynecology and urology surgeons to evaluate the performance of its newly unveiled Carina™ RAS Platform, the first modular robotic-assisted surgery (RAS) platform developed in China for laparoscopic procedures.
Oricell Therapeutics, a Shanghai-based pharmaceutical company committed to advancing tumor cellular immunotherapeutics, raised $45M in Series B1 funding.
Eluminex Biosciences, a Suzhou, China and San Francisco, CA-based biotechnology company focusing on ophthalmic diseases and recombinant human collagen technology, raised $40+ M in Series B funding.
Pudo Robotics, a Shenzhen, China-based commercial service robotics manufacturer, raised Over $15M in Series C3 funding.
LanzaTech NZ, Inc., an innovative leader in carbon capture and transformation and a Qiming Venture Partners portfolio company, listed on Nasdaq on Feb 10 Beijing time, following the completion of its business combination with AMCI Acquisition Corp. II (“AMCI”), a special purpose acquisition company.
Ronovo Surgical, a Shanghai, China-based robotic and digital surgery space company, raised $50M+ in funding.
Iaso Biotherapeutics, a Chinese clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapies and antibody products, completed nearly US $75m ($500 million RMB) in Series C1 funding.
LePure Biotech, a Shanghai, China-based provider of a bioprocessing platform, raised an undisclosed amount in Series C funding.